Archive: 2025/11
The Science Behind Atazanavir: How It Stops HIV From Replicating
Atazanavir is a protease inhibitor that stops HIV from making new infectious copies by blocking a key enzyme. It's taken once daily, has fewer metabolic side effects than older drugs, and remains a key option for first-time treatment and pregnancy.